申请人:Sakuma Shogo
公开号:US08962613B2
公开(公告)日:2015-02-24
A diazepine derivative having the following formula (III) or a pharmacologically acceptable salt thereof is used as A P2X4 receptor antagonist:
wherein each of R21 and R22 is hydrogen, a C1-8 alkyl group or the like;
R23 is hydrogen, a C1-8 alkyl group or the like;
each of R24 and R25 is hydrogen, a C1-8 alkyl group or the like;
R26 is hydrogen, a C1-8 alkyl group, a halogen atom, hydroxyl, nitro, cyano, phenyl optionally having one or more substituents, or a heterocyclic group optionally having one or more substituents or the like; and
p is 0 or 1.
具有以下式(III)或其药理学上可接受的盐的一种二氮平衍生物作为P2X4受体拮抗剂:其中R21和R22中的每一个是氢,C1-8烷基或类似物;R23是氢,C1-8烷基或类似物;R24和R25中的每一个是氢,C1-8烷基或类似物;R26是氢,C1-8烷基,卤素原子,羟基,硝基,氰基,苯基(可选地具有一个或多个取代基)或含有一个或多个取代基的杂环基或类似物;p为0或1。